Ameradas LLC provides a patented solution to a significant problem: the verification of medical ratings and reviews. Our founders have been refining this platform for over two years. They founded Aesthetic Reviews LLC to license the platform and provide a service to aesthetic physicians for publishing honest, positive, and verified patient reviews.
Online ratings & reviews are utilized by more than 75% of consumers (ComScore). These ratings can make or break the reputations of physicians and surgeons. At the same time, they directly and powerfully influence search engine rankings. They are also problematic: with libel, lawsuits, state board issues, and FCC fines occurring often. Reputations are being destroyed for some and fabricated for others.
Ameradas provides a third-party, trusted platform for ratings and reviews verification. It sits at arm’s length above the transactions already taking place amongst patients, physicians, and ratings websites. The platform has two patents issued and multiple patents pending.
Aesthetic Reviews was founded to license the Ameradas platform in the aesthetic health care vertical and provide an efficient, hassle-free method of obtaining and publishing verified, positive reviews. It overcomes the inherent lack of motivation that keeps satisfied patients from publishing positive reviews themselves. Such reviews improve public relations, enhance reputation, and increase search engine rankings. The Aesthetic Reviews publishing platform has multiple patents pending.
Our strategy fundamentally differentiates itself from strategies of potential competitors emerging in the marketplace by (1) enjoying significant intellectual property protection, (2) providing the only real patient verification platform available, (3) integrating with third-party ratings and reviews sites in a cooperative manner, (4) establishing itself as a standard, and (5) establishing a firewall between verification (Ameradas) and marketing (Aesthetic Reviews).
Our founders represent a ‘who’s who’ of experts in the field, having founded and built technology businesses, taken them public, and sold their companies in the past. Principal Founder Robert Baxter founded a multi-million dollar leading Internet strategies firm targeting the aesthetic community and is considered an expert in the field of medical reputation, speaking regularly at industry conferences. President Louis Frisina sold GynoPharma for $73 million, was President of $25 billion Fisher Scientific (NYSE), and later sold Q-Med Inc. (developer of Restylane) to Medicis for $260 million. CTO Richard Veliz took Perfumania public and served as its Chief Technology Officer. VP of Sales William Koontz is well-respected in the aesthetic community and was one of the two highest producing sales managers for Sharper Image. We have also established a world-class Board of Medical Advisors made up of key leaders and opinion influencers within each subset of the aesthetic medical specialties.